(888) 448-0302 Talk to a recovery specialist 24/7

Choosing recovery close to home means your support system is just a few miles away.

  • 100% Confidential
  • Available 24/7
  • No Pressure to Commit
  • Multiple Financial Options Available
Call (888) 448-0302

We're Here To Help 24/7

This Week In Recovery: December 21, 2018

by Landmark Recovery

December 21, 2018
Newspapers sitting on a table

Welcome to This Week in Recovery, a weekly recap of the 5 biggest stories and developments in the recovery industry.

Bipartisan Criminal Justice Reform Bill Emphasizes Treatment Over Punishment

The Senate passed a bill 87 to 12 in favor of criminal justice reforms that shift focus for low level drug offenses to treatment instead of longer punishment.

Called the First Step Act, the bill would help expand job training and programming aimed at reducing recidivism rates among federal prisoners. The bill also expands early-release programs and modifies sentencing laws, including mandatory minimum sentences for nonviolent drug offenders, to more equitably punish drug offenders. Democrats and Republicans believe the bill will also help save money in the long term, based on local models that have shown promise in Oklahoma and Texas.


Vaping Rate Shoots Up Among Teens in 2018

Recently released NIDA data shows that while illicit substance usage is generally declining among teens, vaping rates for nicotine and marijuana continue to skyrocket.

The National Institute on Drug Abuse has released data showing that vaping usage among teens reached new heights in 2018. According to the annual Monitoring the Future Survey, America’s teens reported a dramatic increase in their use of vaping devices between 2017 and 2018, increasing from 27.8% to 37.3%. The year over year increase in prevalence of nicotine vaping translates into nearly 1.3 million more adolescents who vaped this year compared to last year. Added Nora Volkow, MD, director of the National Institute on Drug Abuse (NIDA), “This is a new technology that may in the future be used to administer other types of drugs.


Opioids Offer Little Chronic Pain Benefit, Study Says

A study published in the Journal of the American Medical Association this week found that there is increasing evidence that opioids play a limited role in the treatment of chronic pain.

“Evidence from high-quality studies showed that opioid use was associated with statistically significant but small improvements in pain and physical functioning, and increased risk of vomiting compared with a placebo,” the study said. The benefits they did find tended to decrease over time and come with an increased risk of side effects, including addiction.


Women Who Use Opioids in Postpartum At Risk of Persistent Opioid Use

New research is showing that any postpartum use of opioids is correlated with a higher risk of persistent opioid use.

Research published in the American Journal of Obstetrics and Gynecology found that, regardless of delivery type, postpartum initiation of opioid use was associated with persistent opioid use. The study used data from over 100,000 women who gave birth while covered by Tennessee Medicaid. The women used in the study had not used opioids in the 180 days before they gave birth. “If our estimates were projected to the number of women who give birth annually in the United States, we calculated that every year there would be around 21,000 women becoming chronic opioid users,” the study’s senior author, Dr. Carlos Grijalva of Vanderbilt said.


Congress Accuses Pharmaceutical Companies and DEA of Failure to Stop Flow of Opioids

A new report criticizes the DEA and several pharmaceutical companies for failing to stop the circulation of opioid painkillers in West Virginia.

A report from the House Energy and Commerce Committee found that pharmaceutical drug companies and the Drug Enforcement Agency failed to stop the circulation of millions of prescription pills in rural West Virginia despite a number of warning signs. Drug distributors failed to conduct proper oversight for their customers and the DEA did not correctly monitor the flow of these painkillers from manufacturers to sellers.


Want More Recovery Reads? Check Out Our Blog!


Colin Kroll, Co-Founder of Vine and HQ Trivia, Found Dead of Apparent Overdose

N.Y. police found the body of Colin Kroll, co-founder of Vine and HQ Trivia, on Sunday in his apartment after being reported missing. Kroll was pronounced dead on the scene by first responders, and although medical examiners have yet to pronounce an official verdict, it is believed that the cause of death was drug overdose.